Hiroko Ohgaki

1.2k total citations · 1 hit paper
12 papers, 971 citations indexed

About

Hiroko Ohgaki is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Hiroko Ohgaki has authored 12 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Hiroko Ohgaki's work include Glioma Diagnosis and Treatment (4 papers), Cancer-related Molecular Pathways (4 papers) and Hedgehog Signaling Pathway Studies (3 papers). Hiroko Ohgaki is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Cancer-related Molecular Pathways (4 papers) and Hedgehog Signaling Pathway Studies (3 papers). Hiroko Ohgaki collaborates with scholars based in France, Switzerland and Germany. Hiroko Ohgaki's co-authors include Yasuhiro Yonekawa, Paul Kleihues, Osamu Tachibana, Kazufumi Sato, Kunihiko Watanabe, Paul Kleihues, Paul Kleihues, Mitsutoshi Nakamura, Takao Watanabe and Iver Petersen and has published in prestigious journals such as Carcinogenesis, Acta Neuropathologica and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Hiroko Ohgaki

12 papers receiving 955 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas

1996 564 citations Kunihiko Watanabe, Osamu Tachibana et al. Brain Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroko Ohgaki France	11	552	484	324	306	154	12	971
Marie‐Thérése Stockhausen Denmark	18	557 1.0×	412 0.9×	281 0.9×	272 0.9×	149 1.0×	24	1.1k
Carolyn A. Pedone United States	19	1.0k 1.9×	576 1.2×	371 1.1×	269 0.9×	99 0.6×	27	1.4k
Michimasa Nozaki Japan	11	426 0.8×	276 0.6×	241 0.7×	184 0.6×	70 0.5×	16	784
Jesse Chung‐Sean Pang Hong Kong	23	885 1.6×	493 1.0×	143 0.4×	579 1.9×	127 0.8×	25	1.3k
I‐Mei Siu United States	16	494 0.9×	292 0.6×	160 0.5×	190 0.6×	121 0.8×	22	823
Markus Bredel United States	15	565 1.0×	276 0.6×	251 0.8×	199 0.7×	105 0.7×	28	914
Lara Perryman United Kingdom	13	516 0.9×	327 0.7×	170 0.5×	204 0.7×	89 0.6×	19	850
Demirkan Gursel United States	19	491 0.9×	243 0.5×	270 0.8×	284 0.9×	104 0.7×	32	970
Marta Viana‐Pereira Portugal	14	422 0.8×	363 0.8×	178 0.5×	277 0.9×	123 0.8×	23	787
Anke Waha Germany	19	967 1.8×	215 0.4×	166 0.5×	213 0.7×	85 0.6×	29	1.2k

Countries citing papers authored by Hiroko Ohgaki

Since Specialization

Citations

This map shows the geographic impact of Hiroko Ohgaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Ohgaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Ohgaki more than expected).

Fields of papers citing papers by Hiroko Ohgaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Ohgaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Ohgaki. The network helps show where Hiroko Ohgaki may publish in the future.

Co-authorship network of co-authors of Hiroko Ohgaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Ohgaki. A scholar is included among the top collaborators of Hiroko Ohgaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Ohgaki. Hiroko Ohgaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Watanabe, Takao, Mitsutoshi Nakamura, Yasuhiro Yonekawa, Paul Kleihues, & Hiroko Ohgaki. (2001). Promoter hypermethylation and homozygous deletion of the p14 ARF and p16 INK4a genes in oligodendrogliomas. Acta Neuropathologica. 101(3). 185–189. 71 indexed citations

Reis, Rui Manuel, Akira Hara, Paul Kleihues, & Hiroko Ohgaki. (2001). Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas. Acta Neuropathologica. 102(5). 422–425. 25 indexed citations

Reis, Rui Manuel, Mitsutoshi Nakamura, Jun Masuoka, et al.. (2001). Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomas. Acta Neuropathologica. 101(6). 638–638. 3 indexed citations

Ohgaki, Hiroko, Masakatsu Fukuda, Yasuo Tohma, et al.. (2000). Effect of Intragastric Application ofN-Methylnitrosourea inp53 Knockout Mice. Molecular Carcinogenesis. 28(2). 97–101. 19 indexed citations

Rieger, Johannes, Hiroko Ohgaki, Paul Kleihues, & Michael Weller. (1999). Human astrocytic brain tumors express APO2L/TRAIL. Acta Neuropathologica. 97(1). 1–4. 53 indexed citations

Sato, Kazufumi, Catherine Gratas, Johannes Lampe, et al.. (1997). Reduced Expression of the P2 Form of the Gap Junction Protein Connexin43 in Malignant Meningiomas. Journal of Neuropathology & Experimental Neurology. 56(7). 835–839. 15 indexed citations

Sure, Ulrich, et al.. (1997). Determination of p53 Mutations, EGFR Overexpression, and Loss of p16 Expression in Pediatric Glioblastomas. Journal of Neuropathology & Experimental Neurology. 56(7). 782–789. 77 indexed citations

Watanabe, Kunihiko, Osamu Tachibana, Kazufumi Sato, et al.. (1996). Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas. Brain Pathology. 6(3). 217–223. 564 indexed citations breakdown →

Kleihues, Paul, Adriano Aguzzi, & Hiroko Ohgaki. (1995). Genetic and environmental factors in the etiology of human brain tumors. Toxicology Letters. 82-83. 601–605. 20 indexed citations

10.

Reichel, Martin, et al.. (1994). p53 mutations in primary human lung tumors and their metastases. Molecular Carcinogenesis. 9(2). 105–109. 55 indexed citations

11.

Ohgaki, Hiroko, Paul Kleihues, & Gordon C. Hard. (1991). Ki‐ras mutations in spontaneous and chemically induced renal tumors of the rat. Molecular Carcinogenesis. 4(6). 455–459. 13 indexed citations

12.

Kato, Tamami, et al.. (1989). Induction of tumors in the Zymbal gland, oral cavity, colon, skin and mammary gland of F344 rats by a mutagenic compound, 2-amino_-3, 4-dimethylimidazo[4, 5-f)quinoline. Carcinogenesis. 10(3). 601–603. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact